A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial

Antonio Gonzalez Martin*, Luisa Sanchez Lorenzo, Nicoletta Colombo, René Depont Christensen, Florian Heitz, Mihai Meirovitz, Frederic Selle, Toon Van Gorp, Nuria Alvarez, Javier Sanchez, Carmen Marqués

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Fingeraftryk Dyk ned i forskningsemnerne om 'A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab